Acquisition leverage Rubicon Genomics is now a subsidiary of Takara Bio USA, enhancing credibility and purchasing power. Approach Takara Bio channels to position joint solutions that combine Rubicon’s pre-analytical kits with Takara’s distribution network and customer base.

Pre-analytical strength Specialization in pre-analytical sample processing and amplification can be packaged as a value proposition to labs looking to improve yield from limited or diverse sample sources. Propose bundled workflows that complement existing sequencing and analyses.

Small team, agility With a lean team, emphasize quick pilots and flexible collaboration models. Target niche genomics labs and academic collaborators that benefit from rapid iterations and co-development opportunities.

Strategic partnerships Past collaborations with Agilent and academic partners suggest receptivity to co-marketing and supply agreements. Propose co-branded kits, joint webinars, and bundled offerings with complementary platforms.

Global distribution Takara Bio’s established channels can broaden reach. Present options for direct sales, distributors, or OEM partnerships to accelerate adoption of Rubicon’s kits across regions and accelerate revenue growth.